Your browser doesn't support javascript.
loading
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
Toss, Michael S; Abidi, Asima; Lesche, Dorothea; Joseph, Chitra; Mahale, Sakshi; Saunders, Hugo; Kader, Tanjina; Miligy, Islam M; Green, Andrew R; Gorringe, Kylie L; Rakha, Emad A.
Afiliación
  • Toss MS; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK. msxms8@nottingham.ac.uk.
  • Abidi A; Histopathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt. msxms8@nottingham.ac.uk.
  • Lesche D; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.
  • Joseph C; Cancer Genomics Program, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Mahale S; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Saunders H; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.
  • Kader T; Cancer Genomics Program, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Miligy IM; Cancer Genomics Program, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Green AR; Cancer Genomics Program, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Gorringe KL; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Rakha EA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Br J Cancer ; 122(10): 1496-1506, 2020 05.
Article en En | MEDLINE | ID: mdl-32203210
ABSTRACT

BACKGROUND:

The role of different subtypes of tumour infiltrating lymphocytes (TILs) in breast ductal carcinoma in situ (DCIS) is still poorly defined. This study aimed to assess the prognostic significance of B and T lymphocytes and immune checkpoint proteins expression in DCIS.

METHODS:

A well characterised DCIS cohort (n = 700) with long-term follow-up comprising pure DCIS (n = 508) and DCIS mixed with invasive carcinoma (IBC; n = 192) were stained immunohistochemically for CD20, CD3, CD4, CD8, FOXP3, PD1 and PDL1. Copy number variation and TP53 mutation status were assessed in a subset of cases (n = 58).

RESULTS:

CD3+ lymphocytes were the predominant cell subtype in the pure DCIS cohort, while FOXP3 showed the lowest levels. PDL1 expression was mainly seen in the stromal TILs. Higher abundance of TILs subtypes was associated with higher tumour grade, hormone receptor negativity and HER2 positivity. Mutant TP53 variants were associated with higher levels of stromal CD3+, CD4+ and FOXP3+ cells. DCIS coexisting with invasive carcinoma harboured denser stromal infiltrates of all immune cells and checkpoint proteins apart from CD4+ cells. Stromal PD1 was the most differentially expressed protein between DCIS and invasive carcinoma (Z = 5.8, p < 0.0001). Dense TILs, stromal FOXP3 and PDL1 were poor prognostic factors for DCIS recurrence, while dense TILs were independently associated with poor outcome for all recurrences (HR = 7.0; p = 0.024), and invasive recurrence (HR = 2.1; p = 0.029).

CONCLUSIONS:

Immunosuppressive proteins are potential markers for high risk DCIS and disease progression. Different stromal and intratumoural lymphocyte composition between pure DCIS, DCIS associated with IBC and invasive carcinoma play a potential role in their prognostic significance and related to the underlying genomic instability. Assessment of overall TILs provides a promising tool for evaluation of the DCIS immune microenvironment.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos Infiltrantes de Tumor / Carcinoma Intraductal no Infiltrante / Factores de Transcripción Forkhead / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos Infiltrantes de Tumor / Carcinoma Intraductal no Infiltrante / Factores de Transcripción Forkhead / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido